US Senior Unsecured Healthcare & Pharmaceuticals Corporate Bond Yields (USD)
Fitted spot curve as of 2026-09-11
https://bondscovery.com/yield-curve/usd-corporate-senior-unsecured-healthcare-pharmaceuticals
US Senior Unsecured Healthcare & Pharmaceuticals Corporate Bond Yields (USD) as of 2026-09-11: 10Y at 5.71%, fitted curve 1M–40Y (4.40%–6.19%), 794 bonds. Live chart, constituents and forward rates on bondScovery.
| Maturity | Fitted yield | Forward rate |
|---|---|---|
| 1M | 4.40% | — |
| 3M | 4.43% | 4.45% |
| 6M | 4.49% | 4.64% |
| 9M | 4.56% | 4.88% |
| 12M | 4.65% | 4.88% |
| 18M | 4.83% | 5.28% |
| 2Y | 4.95% | 5.37% |
| 3Y | 5.11% | 5.54% |
| 4Y | 5.24% | 5.78% |
| 5Y | 5.35% | 5.92% |
| 6Y | 5.43% | 6.00% |
| 7Y | 5.50% | 6.12% |
| 8Y | 5.57% | 6.29% |
| 9Y | 5.64% | 6.49% |
| 10Y | 5.71% | 6.65% |
| 15Y | 5.96% | 6.87% |
| 20Y | 6.10% | 7.09% |
| 25Y | 6.19% | 7.18% |
| 30Y | 6.19% | 6.17% |
| 40Y | 6.14% | 5.71% |
2Y, 10Y and the 10Y−2Y spread over time
The 2-year yield is 4.95% and the 10-year 5.71%, a 10Y−2Y spread of +77 bp — positively sloped — as of 2026-09-11. The chart and table below track how they have moved.
Fitted 2Y and 10Y yields and their spread, sampled one build date per month. See all inverted curves today →
| Tenor | Latest2026-09-11 | 1m ago2026-08-12 | 2m ago2026-07-13 | 3m ago2026-06-12 | 4m ago2026-05-14 | 5m ago2026-04-14 | 6m ago2026-03-16 |
|---|---|---|---|---|---|---|---|
| 2Y | 4.95% | 4.71% | 4.63% | 4.57% | 4.45% | 4.34% | 4.13% |
| 10Y | 5.71% | 5.48% | 5.30% | 5.31% | 5.15% | 5.07% | 5.04% |
| 10Y − 2Y | +77 bp | +78 bp | +67 bp | +74 bp | +70 bp | +72 bp | +90 bp |
Yields by rating group
The same curve split by credit quality: 848 rated bonds across 3 rating bands, all maturities pooled. Median yield by band: AAA to AA- 5.30%, A+ to BBB- 5.54%, Speculative 6.14%.
Bonds in this curve
A selection of 30 of the 851 bonds behind this curve, spread across maturities.
| Issuer | Yield | Maturity | Coupon | ISIN |
|---|---|---|---|---|
| Shire Acquisitions Investments Ireland DAC | 6.34% | 2026-09-23 | 3.20% | US82481LAD10 |
| Teva Pharmaceutical Industries LTD | 7.78% | 2026-10-01 | 3.15% | US88167AAE10 |
| Abbvie INC | 4.17% | 2026-11-21 | 2.95% | US00287YBV02 |
| Abbott Laboratories | 4.29% | 2026-11-30 | 3.75% | US002824BF69 |
| Roche Holding AG | 4.87% | 2027-01-28 | 2.38% | USU75000BL90 |
| Baxter International INC | 4.17% | 2027-02-01 | 1.92% | US071813CJ62 |
| Teva Pharmaceutical Industries LTD | 5.17% | 2027-05-09 | 4.75% | US88167AAP66 |
| ELI Lilly & CO | 4.41% | 2027-05-15 | 3.10% | US532457BP26 |
| Becton Dickinson & CO | 4.41% | 2027-08-01 | 7.00% | US075887AN94 |
| ELI Lilly & CO | 4.48% | 2027-08-14 | 4.15% | US532457CP17 |
| Illumina INC | 4.78% | 2027-12-13 | 5.75% | US452327AP42 |
| Cencora INC | 4.77% | 2027-12-15 | 3.45% | US03073EAP07 |
| Edwards Lifesciences Corp | 4.94% | 2028-06-15 | 4.30% | US28176EAD04 |
| Tenet Healthcare Corp | 5.30% | 2028-06-15 | 4.62% | US88033GDH02 |
| Abbvie INC | 5.06% | 2029-03-15 | 4.80% | US00287YDS54 |
| Charles River Laboratories International INC | 5.48% | 2029-03-15 | 3.75% | US159864AG27 |
| Abbvie INC | 5.01% | 2030-03-15 | 4.88% | US00287YDZ97 |
| Abbvie INC | 5.12% | 2030-03-15 | 4.65% | US00287YEM75 |
| Agilent Technologies INC | 5.31% | 2031-03-12 | 2.30% | US00846UAN19 |
| Solventum Corp | 5.45% | 2031-03-13 | 5.45% | US83444MAQ42 |
| BIO-RAD Laboratories INC | 5.58% | 2032-03-15 | 3.70% | US090572AQ17 |
| Abbott Laboratories | 5.25% | 2033-03-15 | 4.30% | US002824BT63 |
| Abbvie INC | 5.35% | 2034-03-15 | 5.05% | US00287YDU01 |
| Abbvie INC | 5.46% | 2035-03-15 | 5.20% | US00287YEA38 |
| Abbott Laboratories | 5.48% | 2036-03-15 | 4.65% | US002824BU37 |
| Pfizer INC | 5.86% | 2039-03-15 | 7.20% | US717081CY74 |
| Abbvie INC | 5.97% | 2044-03-15 | 5.35% | US00287YDV83 |
| ELI Lilly & CO | 6.01% | 2049-03-15 | 3.95% | US532457BT48 |
| Abbvie INC | 6.10% | 2054-03-15 | 5.40% | US00287YDW66 |
| Merck & CO INC | 6.13% | 2061-12-10 | 2.90% | US58933YBG98 |